Rare Biomarkers Specimen Collection and Stabilization Market
The global Rare Biomarkers Specimen Collection and Stabilization Market is witnessing unprecedented growth due to advancements in medical technology, rising prevalence of rare diseases, and increasing demand for personalized medicine. Valued at $23.3 billion in 2021, the market is projected to soar to $54.2 billion by 2031, growing at a CAGR of 8.7% from 2022 to 2031. This article explores key market drivers, challenges, opportunities, and segmental trends.
Comments
Post a Comment